Literature DB >> 20581089

Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity.

G S Gilmartin1, M Lynch, R Tamisier, J W Weiss.   

Abstract

Chronic intermittent hypoxia (CIH) is thought to be responsible for the cardiovascular disease associated with obstructive sleep apnea (OSA). Increased sympathetic activation, altered vascular function, and inflammation are all putative mechanisms. We recently reported (Tamisier R, Gilmartin GS, Launois SH, Pepin JL, Nespoulet H, Thomas RJ, Levy P, Weiss JW. J Appl Physiol 107: 17-24, 2009) a new model of CIH in healthy humans that is associated with both increases in blood pressure and augmented peripheral chemosensitivity. We tested the hypothesis that exposure to CIH would also result in augmented muscle sympathetic nerve activity (MSNA) and altered vascular reactivity contributing to blood pressure elevation. We therefore exposed healthy subjects between the ages of 20 and 34 yr (n = 7) to 9 h of nocturnal intermittent hypoxia for 28 consecutive nights. Cardiovascular and hemodynamic variables were recorded at three time points; MSNA was collected before and after exposure. Diastolic blood pressure (71 +/- 1.3 vs. 74 +/- 1.7 mmHg, P < 0.01), MSNA [9.94 +/- 2.0 to 14.63 +/- 1.5 bursts/min (P < 0.05); 16.89 +/- 3.2 to 26.97 +/- 3.3 bursts/100 heartbeats (hb) (P = 0.01)], and forearm vascular resistance (FVR) (35.3 +/- 5.8 vs. 55.3 +/- 6.5 mmHg x ml(-1) x min x 100 g tissue, P = 0.01) all increased significantly after 4 wk of exposure. Forearm blood flow response following ischemia of 15 min (reactive hyperemia) fell below baseline values after 4 wk, following an initial increase after 2 wk of exposure. From these results we conclude that the increased blood pressure following prolonged exposure to CIH in healthy humans is associated with sympathetic activation and augmented FVR.

Entities:  

Mesh:

Year:  2010        PMID: 20581089      PMCID: PMC4116417          DOI: 10.1152/ajpheart.00253.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  34 in total

1.  Vascular reactivity in obstructive sleep apnea syndrome.

Authors:  H W Duchna; C Guilleminault; R A Stoohs; J L Faul; H Moreno; B B Hoffman; T F Blaschke
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  Automated quantification of sympathetic beat-by-beat activity, independent of signal quality.

Authors:  J W Hamner; J A Taylor
Journal:  J Appl Physiol (1985)       Date:  2001-09

3.  Role of endothelin and endothelin A-type receptor in adaptation of the carotid body to chronic hypoxia.

Authors:  J Chen; L He; B Dinger; L Stensaas; S Fidone
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-06       Impact factor: 5.464

4.  Reduced alpha- and beta(2)-adrenergic vascular response in patients with obstructive sleep apnea.

Authors:  L Grote; H Kraiczi; J Hedner
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

5.  Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea.

Authors:  Eugene C Fletcher
Journal:  Sleep       Date:  2003-02-01       Impact factor: 5.849

Review 6.  Carotid body mechanisms in acclimatization to hypoxia.

Authors:  G E Bisgard
Journal:  Respir Physiol       Date:  2000-07

7.  A pilot study of sleep, cognition, and respiration under 4 weeks of intermittent nocturnal hypoxia in adult humans.

Authors:  Matthew D Weiss; Renaud Tamisier; Judith Boucher; Mekkin Lynch; Geoffrey Gilmartin; J Woodrow Weiss; Robert Joseph Thomas
Journal:  Sleep Med       Date:  2009-03-17       Impact factor: 3.492

8.  Peripheral chemoreflex and baroreflex interactions in cardiovascular regulation in humans.

Authors:  John R Halliwill; Barbara J Morgan; Nisha Charkoudian
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

9.  Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia.

Authors:  Jim Hansen; Mikael Sander
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

10.  Effect of hypoxia on arterial baroreflex control of heart rate and muscle sympathetic nerve activity in humans.

Authors:  John R Halliwill; Christopher T Minson
Journal:  J Appl Physiol (1985)       Date:  2002-09
View more
  42 in total

1.  Ventilatory baroreflex sensitivity in humans is not modulated by chemoreflex activation.

Authors:  Julian M Stewart; Eileen Rivera; Debbie A Clarke; Ila L Baugham; Anthony J Ocon; Indu Taneja; Courtney Terilli; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-11       Impact factor: 4.733

2.  Could Adjunctive Pharmacology Mitigate Cardiovascular Consequences of Obstructive Sleep Apnea?

Authors:  Najib T Ayas; Glen E Foster; Neomi Shah; John Floras; Ismail Laher
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405

3.  Blunted sympathetic neurovascular transduction is associated to the severity of obstructive sleep apnea.

Authors:  Michael K Stickland; Craig D Steinback; Andrew R Steele; Lindsey F Berthelsen; Graham M Fraser; Devin B Phillips; Desi P Fuhr; Eric Y L Wong
Journal:  Clin Auton Res       Date:  2021-02-09       Impact factor: 4.435

4.  Blood Pressure Increases in OSA due to Maintained Neurovascular Sympathetic Transduction: Impact of CPAP.

Authors:  Renaud Tamisier; Can Ozan Tan; Jean-Louis Pepin; Patrick Levy; J Andrew Taylor
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

5.  Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes.

Authors:  Christian Reinke; Shannon Bevans-Fonti; Luciano F Drager; Mi-Kyung Shin; Vsevolod Y Polotsky
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

6.  CPAP therapy prevents increase in blood pressure after upper airway surgery for obstructive sleep apnoea.

Authors:  Maria Teresa Martins de Araújo; Nazaré Sousa Bissoli; Sônia Alves Gouvêa; Maria Christina Thomé Pacheco; Bernard Meyer; Elizardo Corral Vasquez; Bernard Fleury
Journal:  Sleep Breath       Date:  2013-05-06       Impact factor: 2.816

7.  Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization.

Authors:  Keiichi Sumida; Junichi Hoshino; Tatsuya Suwabe; Takatoshi Kasai; Noriko Hayami; Koki Mise; Masahiro Kawada; Aya Imafuku; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Naoki Sawa; Koji Narui; Kenmei Takaichi; Yoshifumi Ubara
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-30       Impact factor: 8.237

8.  Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Keiichi Sumida; Lucia Kwak; Morgan E Grams; Kunihiro Yamagata; Naresh M Punjabi; Csaba P Kovesdy; Josef Coresh; Kunihiro Matsushita
Journal:  Am J Kidney Dis       Date:  2017-07-26       Impact factor: 8.860

Review 9.  Coupling between respiratory and sympathetic activities as a novel mechanism underpinning neurogenic hypertension.

Authors:  Daniel B Zoccal; Benedito H Machado
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

Review 10.  Obstructive sleep apnea and oxygen therapy: a systematic review of the literature and meta-analysis.

Authors:  Vanita Mehta; Tajender S Vasu; Barbara Phillips; Frances Chung
Journal:  J Clin Sleep Med       Date:  2013-03-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.